Sally Beauty (SBH) Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sally Beauty in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBH, but not buy additional shares or sell existing shares.
View SBH analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12 month target prices for Sally Beauty's shares. Their SBH share price forecasts range from $10.00 to $19.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 68.0% from the stock's current price.
View analysts price targets for SBH or view top-rated stocks among Wall Street analysts.

Sally Beauty's stock was trading at $12.52 on January 1st, 2023. Since then, SBH shares have decreased by 33.4% and is now trading at $8.3350.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our SBH earnings forecast.

Sally Beauty Holdings, Inc. (NYSE:SBH) released its earnings results on Thursday, August, 3rd. The specialty retailer reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The specialty retailer earned $931.10 million during the quarter, compared to the consensus estimate of $945.42 million. Sally Beauty had a net margin of 4.33% and a trailing twelve-month return on equity of 52.92%. The business's revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.55 EPS.

Invesco S&P SmallCap Consumer Discretionary ETF holds 21,193 shares of SBH stock, representing 0.95% of its portfolio.

497 employees have rated Sally Beauty Chief Executive Officer Chris Brickman on Glassdoor.com. Chris Brickman has an approval rating of 49% among the company's employees. This puts Chris Brickman in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sally Beauty investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Gran Tierra Energy (GTE), Och-Ziff Capital Management Group (OZM) and Transocean (RIG).

Sally Beauty trades on the New York Stock Exchange (NYSE) under the ticker symbol "SBH."

Sally Beauty's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.69%), Alliancebernstein L.P. (7.62%), ArrowMark Colorado Holdings LLC (6.08%), State Street Corp (4.20%), Champlain Investment Partners LLC (4.00%) and LSV Asset Management (3.58%). Insiders that own company stock include Christian A Brickman, Edward W Rabin, Mark Gregory Spinks and Susan R Mulder.
View institutional ownership trends.

Shares of SBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SBH stock can currently be purchased for approximately $8.34.

Sally Beauty (NYSE:SBH) has a market capitalization of $898.26 million and generates $3.77 billion in revenue each year. The specialty retailer earns $183.55 million in net income (profit) each year or $1.49 on an earnings per share basis.

The company employs 29,000 workers across the globe.

Sally Beauty's mailing address is 3001 COLORADO BOULEVARD, DENTON TX, 76210. The official website for the company is www.sallybeautyholdings.com. The specialty retailer can be reached via phone at (800) 777-5706, via email at jharkins@sallybeauty.com, or via fax at 940-297-4990.